Cart
sales@molnova.com
KT-362 fumarate
CAS No. 105394-80-7
KT-362 fumarate( —— )
Catalog No. M34305 CAS No. 105394-80-7
KT-362 fumarate is a novel compound that acts as an antagonist of calcium channels, potassium channels and sodium channels.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 511 | In Stock |
|
| 5MG | 426 | In Stock |
|
| 10MG | 599 | In Stock |
|
| 25MG | 889 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKT-362 fumarate
-
NoteResearch use only, not for human use.
-
Brief DescriptionKT-362 fumarate is a novel compound that acts as an antagonist of calcium channels, potassium channels and sodium channels.
-
DescriptionKT-362 fumarate is a novel compound that acts as an antagonist of calcium channels, potassium channels and sodium channels.KT-362 fumarate causes vasodilation by affecting intracellular calcium mobilization in atrial muscle cells.KT-362 fumarate has a relaxing effect on femoral and basilar artery strips in rabbits.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel | Potassium Channel | Sodium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number105394-80-7
-
Formula Weight516.61
-
Molecular FormulaC26H32N2O7S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=C/C(O)=O)\C(O)=O.C(CCNCCC1=CC(OC)=C(OC)C=C1)(=O)N2C=3C(=CC=CC3)SCCC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
SAK3
SAK3 (T-VGCC enhancer SAK3) is a potent, orally acitve enhancer of T-type voltage-gated Ca2+ channel (T-VGCC).
-
Oxodipine
Oxodipine, a dihydropyridine-type calcium antagonist, inhibited KCl-induced aortic contraction in rabbits and reduced cardiac force in less potent rat ventricular test-paper contractions.
-
Yangambin
Yangambin is a selective antagonist of the cardiovascular effects of platelet activating factor (PAF); it has hypotensive effect, which is probably due to a peripheral vasodilatation that involves, at least, the inhibition the Ca2+ influx through voltage-gated Ca2+ channels. Yangambin has central nervous system activity, it presents a depressant activity in the open field, forced swimming and pentobarbital sleeping time tests.
